The DOI matches its Crossref record; 102 of the 102 references it cites were found in a registry or an index.
Systemic amyloidosis from A (AA) to T (ATTR): a review
Abstract
Systemic amyloidosis is a rare protein misfolding and deposition disorder leading to progressive organ failure. There are over 15 types of systemic amyloidosis, each caused by a different precursor protein which promotes amyloid formation and tissue deposition. Amyloidosis can be acquired or hereditary and can affect various organs, including the heart, kidneys, liver, nerves, gastrointestinal tract, lungs, muscles, skin and soft tissues. Symptoms are usually insidious and nonspecific resulting in diagnostic delay. The field of amyloidosis has seen significant improvements over the past decade in diagnostic accuracy, prognosis prediction and management. The advent of mass spectrometry‐based shotgun proteomics has revolutionized amyloid typing and has led to the discovery of new amyloid types. Accurate typing of the precursor protein is of paramount importance as the type dictates a specific management approach. In this article, we review each type of systemic amyloidosis to provide the practitioner with practical tools to improve diagnosis and management of these rare disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis
Adams, D., Gonzalez-Duarte, A., O’Riordan, W. D., Yang, C.-C., Ueda, M., Kristen, A. V., Tournev, I., Schmidt, H. H., Coelho, T., Berk, J. L., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1716153 · Cited by 3,047
Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy
Maurer, M. S., Schwartz, J. H., Gundapaneni, B., Elliott, P. M., Merlini, G., Waddington-Cruz, M., Kristen, A. V., Grogan, M., Witteles, R., Damy, T., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1805689 · Cited by 2,857
Self-citationNonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis
Gillmore, J. D., Maurer, M. S., Falk, R. H., Merlini, G., Damy, T., Dispenzieri, A., Wechalekar, A. D., Berk, J. L., Quarta, C. C., Grogan, M., et al. (2016) · Circulation · doi:10.1161/circulationaha.116.021612 · Cited by 2,081
Self-citationInotersen Treatment for Patients with Hereditary Transthyretin Amyloidosis
Benson, M. D., Waddington-Cruz, M., Berk, J. L., Polydefkis, M., Dyck, P. J., Wang, A. K., Planté-Bordeneuve, V., Barroso, F. A., Merlini, G., Obici, L., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1716793 · Cited by 1,452
Self-citationPlasma lipoproteins: apolipoprotein structure and function.
Mahley, R. W., Innerarity, T. L., Rall, S. C., & Weisgraber, K. H. (1984) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)34443-6 · Cited by 1,155
Kumar, S., Dispenzieri, A., Lacy, M. Q., Hayman, S. R., Buadi, F. K., Colby, C., Laumann, K., Zeldenrust, S. R., Leung, N., Dingli, D., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.38.5724 · Cited by 1,137
Self-citationTransthyretin Amyloid Cardiomyopathy
Ruberg, F. L., Grogan, M., Hanna, M., Kelly, J. W., & Maurer, M. S. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.04.003 · Cited by 1,112
Self-citationNatural History and Outcome in Systemic AA Amyloidosis
Lachmann, H. J., Goodman, H. J. B., Gilbertson, J. A., Gallimore, J. R., Sabin, C. A., Gillmore, J. D., & Hawkins, P. N. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa070265 · Cited by 1,032
Dispenzieri, A., Gertz, M. A., Kyle, R. A., Lacy, M. Q., Burritt, M. F., Therneau, T. M., Greipp, P. R., Witzig, T. E., Lust, J. A., Rajkumar, S. V., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.03.029 · Cited by 985
Self-citationPalladini, G., Dispenzieri, A., Gertz, M. A., Kumar, S., Wechalekar, A., Hawkins, P. N., Schönland, S., Hegenbart, U., Comenzo, R., Kastritis, E., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.37.7614 · Cited by 974
Self-citationVrana, J. A., Gamez, J. D., Madden, B. J., Theis, J. D., Bergen, H. R., & Dogan, A. (2009) · Blood · doi:10.1182/blood-2009-07-230722 · Cited by 904
Tafamidis for transthyretin familial amyloid polyneuropathy: A randomized, controlled trial
Coelho, T., Maia, L. F., Martins da Silva, A., Waddington Cruz, M., Planté-Bordeneuve, V., Lozeron, P., Suhr, O. B., Campistol, J. M., Conceição, I. M., Schmidt, H. H.-J., et al. (2012) · Neurology · doi:10.1212/wnl.0b013e3182661eb1 · Cited by 816
A new staging system for cardiac transthyretin amyloidosis
Gillmore, J. D., Damy, T., Fontana, M., Hutchinson, M., Lachmann, H. J., Martinez-Naharro, A., Quarta, C. C., Rezk, T., Whelan, C. J., Gonzalez-Lopez, E., et al. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehx589 · Cited by 776
Systemic Cardiac Amyloidoses: Disease Profiles and Clinical Courses of the 3 Main Types
Rapezzi, C., Merlini, G., Quarta, C. C., Riva, L., Longhi, S., Leone, O., Salvi, F., Ciliberti, P., Pastorelli, F., Biagini, E., et al. (2009) · Circulation · doi:10.1161/circulationaha.108.843334 · Cited by 774
Grogan, M., Scott, C. G., Kyle, R. A., Zeldenrust, S. R., Gertz, M. A., Lin, G., Klarich, K. W., Miller, W. L., Maleszewski, J. J., & Dispenzieri, A. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.06.033 · Cited by 763
Self-citationMisdiagnosis of Hereditary Amyloidosis as AL (Primary) Amyloidosis
Lachmann, H. J., Booth, D. R., Booth, S. E., Bybee, A., Gilbertson, J. A., Gillmore, J. D., Pepys, M. B., & Hawkins, P. N. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa013354 · Cited by 680
Human lysozyme gene mutations cause hereditary systemic amyloidosis
Pepys, M. B., Hawkins, P. N., Booth, D. R., Vigushin, D. M., Tennent, G. A., Soutar, A. K., Totty, N., Nguyen, O., Blake, C. C. F., Terry, C. J., et al. (1993) · Nature · doi:10.1038/362553a0 · Cited by 657
Fontana, M., Pica, S., Reant, P., Abdel-Gadir, A., Treibel, T. A., Banypersad, S. M., Maestrini, V., Barcella, W., Rosmini, S., Bulluck, H., et al. (2015) · Circulation · doi:10.1161/circulationaha.115.016567 · Cited by 626
Holmgren, G., Steen, L., Suhr, O., Ericzon, B.-G., Groth, C.-G., Andersen, O., Wallin, B. G., Seymour, A., Richardson, S., Hawkins, P. N., et al. (1993) · The Lancet · doi:10.1016/0140-6736(93)93127-m · Cited by 579
Maurer, M. S., Bokhari, S., Damy, T., Dorbala, S., Drachman, B. M., Fontana, M., Grogan, M., Kristen, A. V., Lousada, I., Nativi-Nicolau, J., et al. (2019) · Circulation: Heart Failure · doi:10.1161/circheartfailure.119.006075 · Cited by 568
Self-citationBenson, M. D., Buxbaum, J. N., Eisenberg, D. S., Merlini, G., Saraiva, M. J. M., Sekijima, Y., Sipe, J. D., & Westermark, P. (2018) · Amyloid · doi:10.1080/13506129.2018.1549825 · Cited by 566
Systemic immunoglobulin light chain amyloidosis
Merlini, G., Dispenzieri, A., Sanchorawala, V., Schönland, S. O., Palladini, G., Hawkins, P. N., & Gertz, M. A. (2018) · Nature Reviews Disease Primers · doi:10.1038/s41572-018-0034-3 · Cited by 552
Self-citationGenotype and Phenotype of Transthyretin Cardiac Amyloidosis
Maurer, M. S., Hanna, M., Grogan, M., Dispenzieri, A., Witteles, R., Drachman, B., Judge, D. P., Lenihan, D. J., Gottlieb, S. S., Shah, S. J., et al. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.03.596 · Cited by 538
Self-citationCanakinumab for the Treatment of Autoinflammatory Recurrent Fever Syndromes
De Benedetti, F., Gattorno, M., Anton, J., Ben-Chetrit, E., Frenkel, J., Hoffman, H. M., Koné-Paut, I., Lachmann, H. J., Ozen, S., Simon, A., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1706314 · Cited by 486
Diagnosis, Prognosis, and Therapy of Transthyretin Amyloidosis
Gertz, M. A., Benson, M. D., Dyck, P. J., Grogan, M., Coelho, T., Cruz, M., Berk, J. L., Plante-Bordeneuve, V., Schmidt, H. H. J., & Merlini, G. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.09.075 · Cited by 475
Self-citationPalladini, G., Sachchithanantham, S., Milani, P., Gillmore, J., Foli, A., Lachmann, H., Basset, M., Hawkins, P., Merlini, G., & Wechalekar, A. D. (2015) · Blood · doi:10.1182/blood-2015-01-620302 · Cited by 450
Brenner, D. A., Jain, M., Pimentel, D. R., Wang, B., Connors, L. H., Skinner, M., Apstein, C. S., & Liao, R. (2004) · Circulation Research · doi:10.1161/01.res.0000126569.75419.74 · Cited by 450
Muchtar, E., Gertz, M. A., Kumar, S. K., Lacy, M. Q., Dingli, D., Buadi, F. K., Grogan, M., Hayman, S. R., Kapoor, P., Leung, N., et al. (2017) · Blood · doi:10.1182/blood-2016-11-751628 · Cited by 340
Self-citationCoelho, T., Maurer, M. S., & Suhr, O. B. (2013) · Current Medical Research and Opinion · doi:10.1185/03007995.2012.754348 · Cited by 339
Shi, J., Guan, J., Jiang, B., Brenner, D. A., del Monte, F., Ward, J. E., Connors, L. H., Sawyer, D. B., Semigran, M. J., Macgillivray, T. E., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0912263107 · Cited by 336
Ericzon, B.-G., Wilczek, H. E., Larsson, M., Wijayatunga, P., Stangou, A., Pena, J. R., Furtado, E., Barroso, E., Daniel, J., Samuel, D., et al. (2015) · Transplantation · doi:10.1097/tp.0000000000000574 · Cited by 314
Expert consensus recommendations to improve diagnosis of ATTR amyloidosis with polyneuropathy
Adams, D., Ando, Y., Beirão, J. M., Coelho, T., Gertz, M. A., Gillmore, J. D., Hawkins, P. N., Lousada, I., Suhr, O. B., & Merlini, G. (2021) · Journal of Neurology · doi:10.1007/s00415-019-09688-0 · Cited by 314
Self-citationRenal Amyloidosis: Origin and Clinicopathologic Correlations of 474 Recent Cases
Said, S. M., Sethi, S., Valeri, A. M., Leung, N., Cornell, L. D., Fidler, M. E., Herrera Hernandez, L., Vrana, J. A., Theis, J. D., Quint, P. S., et al. (2013) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.10491012 · Cited by 284
Self-citationLight Chain Amyloidosis: Patient Experience Survey from the Amyloidosis Research Consortium
Lousada, I., Comenzo, R. L., Landau, H., Guthrie, S., & Merlini, G. (2015) · Advances in Therapy · doi:10.1007/s12325-015-0250-0 · Cited by 269
AA Amyloidosis: Pathogenesis and Targeted Therapy
Westermark, G. T., Fändrich, M., & Westermark, P. (2015) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-020712-163913 · Cited by 264
Cardiac Scintigraphy With Technetium-99m-Labeled Bone-Seeking Tracers for Suspected Amyloidosis
Hanna, M., Ruberg, F. L., Maurer, M. S., Dispenzieri, A., Dorbala, S., Falk, R. H., Hoffman, J., Jaber, W., Soman, P., Witteles, R. M., et al. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.04.022 · Cited by 255
Self-citationDispenzieri, A., Lacy, M. Q., Katzmann, J. A., Rajkumar, S. V., Abraham, R. S., Hayman, S. R., Kumar, S. K., Clark, R., Kyle, R. A., Litzow, M. R., et al. (2006) · Blood · doi:10.1182/blood-2005-07-2922 · Cited by 253
Self-citationSchönland, S. O., Hegenbart, U., Bochtler, T., Mangatter, A., Hansberg, M., Ho, A. D., Lohse, P., & Röcken, C. (2012) · Blood · doi:10.1182/blood-2011-06-358507 · Cited by 248
Gelsolin: The tail of a molecular gymnast
Nag, S., Larsson, M., Robinson, R. C., & Burtnick, L. D. (2013) · Cytoskeleton · doi:10.1002/cm.21117 · Cited by 239
Kourelis, T., Kumar, S. K., Gertz, M. A., Lacy, M. Q., Buadi, F. K., Hayman, S. R., Zeldenrust, S. R., Leung, N., Kyle, R. A., Russell, S. J., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2013.50.8499 · Cited by 239
Self-citationBochtler, T., Hegenbart, U., Kunz, C., Granzow, M., Benner, A., Seckinger, A., Kimmich, C., Goldschmidt, H., Ho, A. D., Hose, D., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.57.4947 · Cited by 234
Amyloid Typing by Mass Spectrometry in Clinical Practice: a Comprehensive Review of 16,175 Samples
Dasari, S., Theis, J. D., Vrana, J. A., Rech, K. L., Dao, L. N., Howard, M. T., Dispenzieri, A., Gertz, M. A., Hasadsri, L., Highsmith, W. E., et al. (2020) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2020.06.029 · Cited by 230
Self-citationWhat is new in diagnosis and management of light chain amyloidosis?
Palladini, G., & Merlini, G. (2016) · Blood · doi:10.1182/blood-2016-01-629790 · Cited by 227
Kaufman, G. P., Schrier, S. L., Lafayette, R. A., Arai, S., Witteles, R. M., & Liedtke, M. (2017) · Blood · doi:10.1182/blood-2017-01-763599 · Cited by 225
A practical approach to the diagnosis of systemic amyloidoses
Fernández de Larrea, C., Verga, L., Morbini, P., Klersy, C., Lavatelli, F., Foli, A., Obici, L., Milani, P., Capello, G. L., Paulli, M., et al. (2015) · Blood · doi:10.1182/blood-2014-11-609883 · Cited by 208
Papa, R., & Lachmann, H. J. (2018) · Rheumatic Disease Clinics of North America · doi:10.1016/j.rdc.2018.06.004 · Cited by 199
Hereditary Systemic Amyloidosis Due to Asp76Asn Variant β2-Microglobulin
Valleix, S., Gillmore, J. D., Bridoux, F., Mangione, P. P., Dogan, A., Nedelec, B., Boimard, M., Touchard, G., Goujon, J.-M., Lacombe, C., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1201356 · Cited by 186
Leukocyte chemotactic factor 2: A novel renal amyloid protein
Benson, M. D., James, S., Scott, K., Liepnieks, J. J., & Kluve-Beckerman, B. (2008) · Kidney International · doi:10.1038/ki.2008.152 · Cited by 173
Diagnosis, Pathogenesis, Treatment, and Prognosis of Hereditary Fibrinogen Aα-Chain Amyloidosis
Gillmore, J. D., Lachmann, H. J., Rowczenio, D. M., Gilbertson, J. A., Zeng, C., Liu, Z.-H., Leishi, L., Wechalekar, A. D., & Hawkins, P. N. (2008) · Journal of the American Society of Nephrology · doi:10.1681/asn.2008060614 · Cited by 172
11C-Pittsburgh B PET Imaging in Cardiac Amyloidosis
Lee, S.-P., Lee, E. S., Choi, H., Im, H.-J., Koh, Y., Lee, M.-H., Kwon, J.-H., Paeng, J. C., Kim, H.-K., Cheon, G. J., et al. (2015) · JACC: Cardiovascular Imaging · doi:10.1016/j.jcmg.2014.09.018 · Cited by 171
Sanchorawala, V., Sarosiek, S., Schulman, A., Mistark, M., Migre, M. E., Cruz, R., Sloan, J. M., Brauneis, D., & Shelton, A. C. (2020) · Blood · doi:10.1182/blood.2019004436 · Cited by 164
Benson, M. D., Liepnieks, J. J., Yazaki, M., Yamashita, T., Asl, K. H., Guenther, B. D., & Kluve‐Beckerman, B. (2001) · Genomics · doi:10.1006/geno.2000.6499 · Cited by 157
A Modern Primer on Light Chain Amyloidosis in 592 Patients With Mass Spectrometry–Verified Typing
Muchtar, E., Gertz, M. A., Kyle, R. A., Lacy, M. Q., Dingli, D., Leung, N., Buadi, F. K., Hayman, S. R., Kapoor, P., Hwa, Y. L., et al. (2019) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2018.08.006 · Cited by 142
Self-citationRoussel, M., Merlini, G., Chevret, S., Arnulf, B., Stoppa, A. M., Perrot, A., Palladini, G. O., Karlin, L., Royer, B., Huart, A., et al. (2020) · Blood · doi:10.1182/blood.2019004369 · Cited by 140
Stangou, A. J., Banner, N. R., Hendry, B. M., Rela, M., Portmann, B. C., Wendon, J. A., Monaghan, M. J., MacCarthy, P. A., Buxton-Thomas, M. S., Mathias, C. J., et al. (2009) · Blood · doi:10.1182/blood-2009-06-223792 · Cited by 139
Suhr, O. B., Lundgren, E., & Westermark, P. (2017) · Journal of Internal Medicine · doi:10.1111/joim.12585 · Cited by 137
Lovat, L. B., Persey, M. R., Madhoo, S., et al. (1998) · Gut · doi:10.1136/gut.42.5.727 · Cited by 133
Liepnieks, J. J., & Benson, M. D. (2007) · Amyloid · doi:10.1080/13506120701614032 · Cited by 132
Stem Cell Transplantation for Light Chain Amyloidosis: Decreased Early Mortality Over Time
Sidiqi, M. H., Aljama, M. A., Buadi, F. K., Warsame, R. M., Lacy, M. Q., Dispenzieri, A. A., Dingli, D., Gonsalves, W. I., Kumar, S. K., Kapoor, P., et al. (2018) · Journal of Clinical Oncology · doi:10.1200/jco.2017.76.9554 · Cited by 127
Self-citationTreatment of Immunoglobulin Light Chain Amyloidosis
Dispenzieri, A. A., Buadi, F. K., Kumar, S. K., Reeder, C. B., Sher, T., Lacy, M. Q., Kyle, R. A., Mikhael, J. R., Roy, V., Leung, N., et al. (2015) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2015.06.009 · Cited by 121
Self-citationAmyloidogenicity and Clinical Phenotype Associated with Five Novel Mutations in Apolipoprotein A-I
Rowczenio, D. M., Doǧan, A., Theis, J. D., Vrana, J. A., Lachmann, H. J., Wechalekar, A. D., Gilbertson, J. A., Hunt, T., Gibbs, S. D., Sattianayagam, P. T., et al. (2011) · American Journal Of Pathology · doi:10.1016/j.ajpath.2011.06.024 · Cited by 119
Characterization and outcomes of renal leukocyte chemotactic factor 2-associated amyloidosis
Said, S. M., Sethi, S. M., Valeri, A. M., Chang, A., Nast, C. C., Krahl, L., Molloy, P. J., Barry, M., Fidler, M. E., Cornell, L. D., et al. (2014) · Kidney International · doi:10.1038/ki.2013.558 · Cited by 117
Self-citationSolomon, J. P., Page, L. J., Balch, W. E., & Kelly, J. W. (2012) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409238.2012.661401 · Cited by 115
Amyloidosis: Insights from Proteomics
Doǧan, A. (2016) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathol-052016-100200 · Cited by 109
Koike, H., Ando, Y., Ueda, M., Kawagashira, Y., Iijima, M., Fujitake, J., Hayashi, M., Yamamoto, M., Mukai, E., Nakamura, T., et al. (2009) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2009.07.028 · Cited by 107
Risk of transmission of systemic transthyretin amyloidosis after domino liver transplantation
Lladó, L., Baliellas, C., Casasnovas, C., Ferrer, I., Fabregat, J., Ramos, E., Castellote, J., Torras, J., Xiol, X., & Rafecas, A. (2010) · Liver Transplantation · doi:10.1002/lt.22174 · Cited by 103
Advances in the treatment of hereditary transthyretin amyloidosis: a review
Gertz, M. A., Mauermann, M. L., Grogan, M., & Coelho, T. (2019) · Brain and Behavior · doi:10.1002/brb3.1371 · Cited by 102
Self-citationStabilization of Cardiac Function With Diflunisal in Transthyretin (ATTR) Cardiac Amyloidosis
Lohrmann, G., Pipilas, A., Mussinelli, R., Gopal, D., Berk, J., Connors, L., Vellanki, N. S., Hellawell, J. L., Siddiqi, O., Fox, J., et al. (2019) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2019.11.024 · Cited by 95
Oliva, L., Orfanelli, U., Resnati, M., Raimondi, A., Orsi, A., Milan, E., Palladini, G. O., Milani, P., Cerruti, F., Cascio, P., et al. (2017) · Blood · doi:10.1182/blood-2016-08-730978 · Cited by 94
Pinney, J. H., Lachmann, H. J., Sattianayagam, P. T., Gibbs, S. D., Wechalekar, A. D., Venner, C. P., Whelan, C. J., Gilbertson, J. A., Rowczenio, D. M., Hawkins, P. N., et al. (2012) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2012.04326.x · Cited by 91
Clinical, morphologic, and genetic features of renal leukocyte chemotactic factor 2 amyloidosis
Larsen, C. P., Kossmann, R. J., Beggs, M. L., Solomon, A., & Walker, P. D. (2014) · Kidney International · doi:10.1038/ki.2014.11 · Cited by 88
Mereuta, O. M., Theis, J. D., Vrana, J. A., Law, M. E., Grogg, K. L., Dasari, S., Chandan, V. S., Wu, T., Jimenez-Zepeda, V. H., Fonseca, R., et al. (2014) · Blood · doi:10.1182/blood-2013-07-517938 · Cited by 85
Self-citationSattianayagam, P. T., Gibbs, S. D., Rowczenio, D. M., Pinney, J. H., Wechalekar, A. D., Gilbertson, J. A., Hawkins, P. N., Lachmann, H. J., & Gillmore, J. D. (2011) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2011.02470.x · Cited by 84
Outcomes of adults with restrictive cardiomyopathy after heart transplantation
DePasquale, E. C., Nasir, K., & Jacoby, D. L. (2012) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2012.09.018 · Cited by 83
Daratumumab-based therapy in patients with heavily-pretreated AL amyloidosis
Abeykoon, J. P., Zanwar, S., Dispenzieri, A. A., et al. (2018) · Leukemia · doi:10.1038/s41375-018-0262-2 · Cited by 83
Self-citationMuchtar, E., Buadi, F. K., Dispenzieri, A. A., & Gertz, M. A. (2016) · Acta Haematologica · doi:10.1159/000443200 · Cited by 79
Self-citationGranel, B., Valleix, S., Serratrice, J., Cherin, P., Texeira, A., DISDIER, P., Weiller, P., & Grateau, G. (2006) · Medicine · doi:10.1097/01.md.0000200467.51816.6d · Cited by 75
Prevalence of Monoclonal Gammopathy in Wild-Type Transthyretin Amyloidosis
Geller, H. I., Singh, A., Mirto, T. M., Padera, R. F., Mitchell, R. N., Laubach, J. P., & Falk, R. H. (2017) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2017.09.016 · Cited by 75
Hereditary gelsolin amyloidosis
Kiuru‐Enari, S., & Haltia, M. (2013) · Handbook of clinical neurology · doi:10.1016/b978-0-444-52902-2.00039-4 · Cited by 74
Tafamidis for transthyretin familial amyloid polyneuropathy: A randomized, controlled trial
Merkies, I. S. J. (2013) · Neurology · doi:10.1212/01.wnl.0000429338.33391.87 · Cited by 72
Grogan, M. A., Gertz, M. A., McCurdy, A. B. R., et al. (2016) · World Journal of Transplantation · doi:10.5500/wjt.v6.i2.380 · Cited by 69
Self-citationValleix, S., Verona, G., Jourde‐Chiche, N., Nédelec, B., Mangione, P. P., Bridoux, F., Mangé, A., Doǧan, A., Goujon, J., Lhomme, M., et al. (2016) · Nature Communications · doi:10.1038/ncomms10353 · Cited by 67
Ten‐year survivors in AL amyloidosis: characteristics and treatment pattern
Muchtar, E., Gertz, M. A., Lacy, M. Q., Go, R. S., Buadi, F. K., Dingli, D., Grogan, M. A., AbouEzzeddine, O. F., Hayman, S. R., Kapoor, P., et al. (2019) · British Journal of Haematology · doi:10.1111/bjh.16096 · Cited by 66
Self-citationOrthotopic liver transplantation for hereditary fibrinogen amyloidosis
Zeldenrust, S. R., Gertz, M. A., Uemichi, T., Björnsson, J., Wiesner, R. J., Schwab, T., & Benson, M. D. (2003) · Transplantation · doi:10.1097/01.tp.0000046526.10003.ec · Cited by 60
Self-citationTakei, Y., Gono, T., Yazaki, M., Ikeda, S., Ikegami, T., Hashikura, Y., Miyagawa, S., & Hoshii, Y. (2006) · Liver Transplantation · doi:10.1002/lt.20954 · Cited by 59
Pathogenesis of β2‐microglobulin amyloidosis
Ohashi, K. (2001) · Pathology International · doi:10.1046/j.1440-1827.2001.01156.x · Cited by 59
Nelson, L. M., Penninga, L., Sander, K., Hansen, P. B., Villadsen, G. E., Rasmussen, A., & Gustafsson, F. (2012) · Clinical Transplantation · doi:10.1111/ctr.12053 · Cited by 57
Diagnostic value of abdominal wall fat pad biopsy in senile systemic amyloidosis
Ikeda, S., Sekijima, Y., Tojo, K., & Koyama, J. (2011) · Amyloid · doi:10.3109/13506129.2011.623199 · Cited by 55
Diagnosis, pathogenesis and outcome in leucocyte chemotactic factor 2 (ALECT2) amyloidosis
Rezk, T., Gilbertson, J. A., Rowczenio, D. M., Bass, P., Lachmann, H. J., Wechalekar, A. D., Fontana, M., Mahmood, S., Sachchithanantham, S., Whelan, C. J., et al. (2016) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfw375 · Cited by 50
Muchtar, E., Gertz, M. A., Kourelis, T., Sidana, S., Go, R. S., Lacy, M. Q., Buadi, F. K., Dingli, D., Hayman, S. R., Kapoor, P., et al. (2019) · Leukemia · doi:10.1038/s41375-019-0655-x · Cited by 50
Self-citationLeukocyte cell-derived chemotaxin-2: it's role in pathophysiology and future in clinical medicine
Slowik, V, & Apte, U. (2017) · Clinical and Translational Science · doi:10.1111/cts.12469 · Cited by 44
Fibrinogen alpha amyloidosis: insights from proteomics
Chapman, J. R., & Doǧan, A. (2019) · Expert Review of Proteomics · doi:10.1080/14789450.2019.1659137 · Cited by 40
Obesity is a significant susceptibility factor for idiopathic AA amyloidosis
Blank, N., Hegenbart, U., Dietrich, S., Brune, M., Beimler, J., Röcken, C., Müller‐Tidow, C., Lorenz, H., & Schönland, S. O. (2018) · Amyloid · doi:10.1080/13506129.2018.1429391 · Cited by 39
Muchtar, E., Dispenzieri, A. A., Jevremović, D., Dingli, D., Buadi, F. K., Lacy, M. Q., Gonsalves, W. I., Warsame, R. M., Kourelis, T., Hayman, S. R., et al. (2019) · Amyloid · doi:10.1080/13506129.2019.1666709 · Cited by 34
Self-citationApolipoprotein CII Amyloidosis Associated With p.Lys41Thr Mutation
Sethi, S. M., Dasari, S., Plaisier, E. M., Ronco, P. M., Nasr, S. H., Brochériou, I., Theis, J. D., Vrana, J. A., Zimmermann, M. T., Quint, P. S., et al. (2018) · Kidney International Reports · doi:10.1016/j.ekir.2018.04.009 · Cited by 29
Self-citationWong, S. W. K., Hegenbart, U., Palladini, G. O., Shah, G. L., Landau, H. J., Warner, M. T., Toskic, D., Jaccard, A., Hansen, T., Bladé, J., et al. (2018) · Clinical Lymphoma Myeloma & Leukemia · doi:10.1016/j.clml.2018.07.292 · Cited by 25
Self-citationPrognostic Significance of Holter Monitor Findings in Patients With Light Chain Amyloidosis
Sidana, S., Tandon, N., Brady, P. A., Grogan, M. A., Gertz, M. A., Dispenzieri, A. A., Lin, G., Dingli, D., Buadi, F. K., Lacy, M. Q., et al. (2019) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2018.08.039 · Cited by 23
Self-citationIsolated heart transplantation for familial transthyretin (TTR) V122I cardiac amyloidosis
Thenappan, T., Fedson, S., Rich, J., Murks, C., Husain, A. N., Pogoriler, J. E., & Anderson, A. S. (2014) · Amyloid · doi:10.3109/13506129.2013.853660 · Cited by 22
LECT2 Amyloidosis in Kidney Transplantation: A Report of 5 Cases
Mejia-Vilet, J. M., Mastrascusa, L. C., Palacios-Cebreros, E. J., Reyes-Macedo, M., Portilla-Jiménez, A., Morales-Buenrostro, L. E., Cohen‐Bucay, A., Niño-Cruz, J. A., & Uribe‐Uribe, N. (2019) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2018.10.016 · Cited by 17
Sidiqi, M. H., Aljama, M. A., Jevremović, D., Muchtar, E., Buadi, F. K., Warsame, R. M., Lacy, M. Q., Dispenzieri, A. A., Dingli, D., Gonsalves, W. I., et al. (2018) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2018.06.027 · Cited by 16
Self-citationMuchtar, E., Grogan, M. A., Dasari, S., Kurtin, P. J., & Gertz, M. A. (2017) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2017.06.013 · Cited by 11
Self-citationNelson, L. M., Penninga, L., Sander, K., et al. (2011) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2011.01.543 · Cited by 4
Cited by
Design of amyloidogenic peptide traps
Sahtoe, D. D., Andrzejewska, E. A., Han, H. L., Rennella, E., Schneider, M. M., Meisl, G., Ahlrichs, M., Decarreau, J., Nguyen, H., Kang, A., et al. (2024) · Nature Chemical Biology · doi:10.1038/s41589-024-01578-5 · Cited by 48
Grogan, M., Lopez‐Jimenez, F., Guthrie, S., Kumar, N., Langevin, R., Lousada, I., Witteles, R., Royyuru, A., Rosenzweig, M., Cairns‐Smith, S., et al. (2025) · Journal of the American Heart Association · doi:10.1161/jaha.124.036533 · Cited by 26
Self-citationFraile-Ramos, J., Garrit, A., Reig-Vilallonga, J., & Giménez-Llort, L. (2023) · Cells · doi:10.3390/cells12111517 · Cited by 26
AmyloGram reveals amyloidogenic potential in stroke thrombus proteomes
Kell, D. B., Doyle, K. M., Salcedo-Sora, J. E., Sekhar, A., Walker, M., & Pretorius, E. (2025) · Biochemical Journal · doi:10.1042/bcj20253317 · Cited by 4
Metadata
- Authors
- Muchtar, E., Dispenzieri, A., Magen, H., Grogan, M., Mauermann, M., McPhail, E. D., Kurtin, P. J., Leung, N., Buadi, F. K., Dingli, D., Kumar, S. K., & Gertz, M. A.
- Venue
- Journal of Internal Medicine
- Publisher
- Wiley
- Published
- 2020-09-14
- Volume
- 289
- Issue
- 3
- Pages
- 268-292
- ISSN
- 0954-6820 (ISSN-L)
- 1365-2796
- OpenAlex
- W3085262612
- Cited by
- 327
- References
- 102
- FWCI
- 9.06
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.